Type / Class
Equity / Ordinary Shares, nominal value EUR0.15 per share
Shares outstanding
188M
Number of holders
18
Total 13F shares, excl. options
5.27M
Shares change
+753K
Total reported value, excl. options
$64.3M
Value change
+$9.26M
Number of buys
10
Number of sells
-7
Price
$12.20

Significant Holders of Valneva SE - Ordinary Shares, nominal value EUR0.15 per share (VALN) as of Q3 2025

21 filings reported holding VALN - Valneva SE - Ordinary Shares, nominal value EUR0.15 per share as of Q3 2025.
Valneva SE - Ordinary Shares, nominal value EUR0.15 per share (VALN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.27M shares of 188M outstanding shares and own 2.8% of the company stock.
Largest 10 shareholders include NOVO HOLDINGS A/S (2.35M shares), Frazier Life Sciences Management, L.P. (2.29M shares), GENERAL AMERICAN INVESTORS CO INC (354K shares), WELLS FARGO & COMPANY/MN (154K shares), MORGAN STANLEY (33K shares), MARSHALL WACE, LLP (31.2K shares), IRONWOOD INVESTMENT MANAGEMENT LLC (25.1K shares), CITADEL ADVISORS LLC (16.4K shares), JPMORGAN CHASE & CO (10.2K shares), and VSM Wealth Advisory, LLC (9K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.